Wegovy Programme - Sources
Sources and small print
** Results are based on the STEP 1 Wegovy trial. Results vary – weight loss can be more or less than the 15% average.
Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" New England Journal of Medicine, 384(11)
https://doi.org/10.1056/NEJMoa2032183
*** An admin fee may apply for early cancellation. See our terms and conditions.
Contact Details
17 D-F Telford Court, Chestergates Business Park, Chester, United Kingdom, CH1 6LT.
Quick Links
Guides
We only offer our programme in the UK and Northern Ireland. We are currently unable to deliver to the Republic of Ireland.
© 2025
All Rights Reserved | SemaPen Ltd. | Digital marketing from My Digital Hero